REPL is Replimune Group, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $15.98. Market cap: $1.48B. Capital Quality Rank: 39/100 — Stagnant mediocrity.
Stock snapshot
| Price | $15.98 |
| Market cap | $1.48B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 39 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -125.1% |
| Shareholder buyback yield | -13.19% |
| Altman Z-score zone | Safe |
About REPL
Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.
Related non-dividend companies
Other non-dividend stocks investors research alongside REPL. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is REPL's current stock price?
REPL (Replimune Group, Inc.) is currently trading at $15.98.
Does REPL pay a dividend?
REPL (Replimune Group, Inc.) does not currently pay a regular dividend.
What is REPL's Capital Quality Rank?
REPL has a Capital Quality Rank of 39/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track REPL in DiviDrip
Add REPL to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search REPL and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.